Volume 11 - Issue 6 - June 2003
09/04/2008
I s dermatology today being drawn into two distinct camps? If so, the battle lines might be drawn this way: On one side sits a growing army of cosmetic/surgical dermatologists armed with lasers, Botox injections, and a cadre of patients happy...
I s dermatology today being drawn into two distinct camps? If so, the battle lines might be drawn this way: On one side sits a growing army of cosmetic/surgical dermatologists armed with lasers, Botox injections, and a cadre of patients happy...
I s dermatology today being...
09/04/2008
The Dermatologist
09/04/2008
Skin & Aging is proud to bring you this latest installment in its CME series. This series consists of regular CME activities that qualify you for two category 1 physician credit hours. As a reader of Skin & Aging, this course is...
Skin & Aging is proud to bring you this latest installment in its CME series. This series consists of regular CME activities that qualify you for two category 1 physician credit hours. As a reader of Skin & Aging, this course is...
Skin & Aging is proud to...
09/04/2008
The Dermatologist
09/04/2008
Unsuspected Drainage Patterns
With widespread use of lymphatic mapping and sentinel lymphadenectomy, more precise mapping of the drainage of a primary cutaneous melanoma has developed. With this precision, several previously held beliefs...
Unsuspected Drainage Patterns
With widespread use of lymphatic mapping and sentinel lymphadenectomy, more precise mapping of the drainage of a primary cutaneous melanoma has developed. With this precision, several previously held beliefs...
Unsuspected Drainage Patterns...
09/04/2008
The Dermatologist
09/04/2008
U ntil recently, no viable economic model existed for the ongoing, profitable deployment of teledermatology systems. Consequently, most teledermatology systems had disbanded when the grants stopped. Without the incentives that adequate...
U ntil recently, no viable economic model existed for the ongoing, profitable deployment of teledermatology systems. Consequently, most teledermatology systems had disbanded when the grants stopped. Without the incentives that adequate...
U ntil recently, no viable...
09/04/2008
The Dermatologist
Chief Medical Editor Message
09/04/2008
Ethics in practice is an issue that continues to spur debate among all healthcare practitioners, but over the last couple of years the debate seems to have reached a new level.
Gift giving by pharmaceutical manufacturers to physicians has...
Ethics in practice is an issue that continues to spur debate among all healthcare practitioners, but over the last couple of years the debate seems to have reached a new level.
Gift giving by pharmaceutical manufacturers to physicians has...
Ethics in practice is an issue...
09/04/2008
The Dermatologist
Coding and Billing
09/04/2008
Now that many of you are aware that the Medicare pay rates have finally been settled for 2003, you’re probably still scratching your head and wondering, What’s the bottom line? After months of Congressional juggling, fee schedule and...
Now that many of you are aware that the Medicare pay rates have finally been settled for 2003, you’re probably still scratching your head and wondering, What’s the bottom line? After months of Congressional juggling, fee schedule and...
Now that many of you are aware...
09/04/2008
The Dermatologist
09/04/2008
A team led by the National Human Genome Research Institute recently announced the discovery of the genetic basis of a disorder that causes the most dramatic form of premature aging. This finding will help shed light on the rare disease, as...
A team led by the National Human Genome Research Institute recently announced the discovery of the genetic basis of a disorder that causes the most dramatic form of premature aging. This finding will help shed light on the rare disease, as...
A team led by the National...
09/04/2008
The Dermatologist
09/04/2008
Imiquimod for AKs
3M, the manufacturer of imiquimod (Aldara) is seeking FDA approval for use of its drug to treat actinic keratosis. Already approved for treating genital warts, imiquimod has shown promise in treating AKs in clinical...
Imiquimod for AKs
3M, the manufacturer of imiquimod (Aldara) is seeking FDA approval for use of its drug to treat actinic keratosis. Already approved for treating genital warts, imiquimod has shown promise in treating AKs in clinical...
Imiquimod for AKs
3M, the...
09/04/2008
The Dermatologist
09/04/2008
Parents Stressed over Children’s Hemangiomas
A recent study reported that the parents of children with hemangiomas are more likely to experience emotional and psychological distress over their child’s condition than the children themselves....
Parents Stressed over Children’s Hemangiomas
A recent study reported that the parents of children with hemangiomas are more likely to experience emotional and psychological distress over their child’s condition than the children themselves....
Parents Stressed over...
09/04/2008
The Dermatologist
09/04/2008
The average cost of developing a new prescription drug is $897 million, almost four times the cost in the early 1990s, according to a study by the Tufts Center for the Study of Drug Development, Bloomberg/Bern Record reports. Results of the...
The average cost of developing a new prescription drug is $897 million, almost four times the cost in the early 1990s, according to a study by the Tufts Center for the Study of Drug Development, Bloomberg/Bern Record reports. Results of the...
The average cost of developing...
09/04/2008
The Dermatologist
